BioMed Research International / 2020 / Article / Tab 2

Research Article

In Vitro Evaluation of Curcumin-Encapsulated Chitosan Nanoparticles against Feline Infectious Peritonitis Virus and Pharmacokinetics Study in Cats

Table 2

Characterisation parameters of chitosan nanoparticles and Cur-CS nanoparticles.

Chitosan/curcumin ratioMean particle size (nm)Zeta potential (mV)Encapsulation efficacy (%)Drug loading (%)

Cur-CS nanoparticles1 : 1aNDaa
1 : 0.75bbb
1 : 0.5bNDbb
Chitosan nanoparticlesc

Data are presented as () and analysed using one-way ANOVA and post hoc Duncan multiple test. For each parameter, means within a column with different roman letters were significantly different () from each other. Cur-CS: curcumin-encapsulated chitosan; ND: not determined.

We are committed to sharing findings related to COVID-19 as quickly as possible. We will be providing unlimited waivers of publication charges for accepted research articles as well as case reports and case series related to COVID-19. Review articles are excluded from this waiver policy. Sign up here as a reviewer to help fast-track new submissions.